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Abstract 
Background&Aims: Thyroid disorders are frequently associated 
with diabetes in clinical practice. In type 1 diabetes, because autoimmune 
etiology it is often associated with autoimmune thyroid disease (chronic 
autoimmune thyroiditis, Basedow-Graves disease). The purpose of this study 
is to asses the prevalence of different types of thyroid disorders in a group of 
children with diabetes mellitus (DM) type 1. Methods: The studied group 
was represented by 83 children with diabetes mellitus type 1 (71 F and 12 
M), aged between 7 and 17 years. Were used clinical, biochemical and 
imaging parameters. Results: Regarding the type of thyroid disease, 
prevailed ACT - 65.06% (87.03% F vs. 12.97% M, p<0.001, X2= 59.26), 
followed by diffuse euthyroid goiter - 30.12% (80% F vs. 20% M, p<0.001, 
X2= 18) and Graves-Basedow disease - 4.82% (100% F vs. 0% M, p = 0.006, 
X2= 8). For each thyroid disease we determined the actual mean age, the 
onset mean age of thyroid disease and diabetes, the mean duration of 
diabetes and thyroid disease, mean BMI, glucose and HbA1c. We found 
significant differences between these three thyroid disease regarding actual 
age, onset age of diabetes, diabetes and thyroid disease duration.  We don’t 
found significant differences regarding BMI, blood glucose and HbA1c. 
Conclusion: In children with type 1 diabetes we found a net predominance 
of female and were prevailed autoimmune diseases such as part of the 
polyglandular autoimmune syndrome.  
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Introduction 
Thyroid disorders are frequently associated with diabetes in clinical 
practice. In type 1 diabetes, because autoimmune etiology it is often 
associated with autoimmune thyroid disease (chronic autoimmune 
thyroiditis, Basedow-Graves disease).  
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Thyroid disorders are common in the general population, their 
prevalence increases with age. Screening for thyroid disease is indicated in 
certain high-risk groups, such as infants and the elderly [Wu, 2000]. 
Hypothyroidism is the most common thyroid disease in the adult 
population and at older women. Usually they have autoimmune origin, 
presenting as atrophic primary hypothyroidism or Hashimoto thyroiditis. It 
may be also secondary to treatment with radioactive iodine or thyroid 
surgery. In rare cases, may occur secondary hypothyroidism to hypothalamic 
or pituitary disease [Wu, 2000]. 
By contrast, hyperthyroidism is less common, with a female / male 
ratio of 9/1. Graves' disease is the most common and usually affects young 
adults. Toxic multinodular goiter usually occurs in the elderly [Wu, 2000]. 
The patients with diabetes have a high prevalence of thyroid disease 
compared with non-diabetic population [Wu, 2000]. 
Because patients with organ specific autoimmune disease are at risk 
of developing other autoimmune diseases and thyroid disorders are more 
common in women, it is not surprising that 30% of women with type 1 
diabetes present thyroid disorders. The rates of postpartum thyroiditis in 
diabetic patients are three times higher than in healthy women [Wu, 2000]. 
Type 1 diabetes is often associated with endocrine and  systemic 
disease with autoimmune etiology such as Graves-Basedow disease, 
Hashimoto's thyroiditis, Addison's disease, celiac disease, pernicious anemia, 
myasthenia gravis, vitiligo, etc. [Cooper et al, 2003]. 
From people with type 1 diabetes, ≈ 1 in 100 patients will develop 
Graves' disease [De Block, 2000] and ≈ 1 in 20 patients are generally 
affected by hypothyroidism [De Block, 2000]. Frequency of DM type 1 
association with hyperthyroidism and hypothyroidism varies from 3.2% to 
4.6% and from 0.7% to 4% [Radaideh et al, 2003]. 
A private association of DM type 1 with hypo-or hyperthyroidism is 
characteristic for polyglandular autoimmune syndrome. 
 
Material And Method 
Method 
Investigated Population 
83 children with diabetes mellitus type 1 (71 F and 12 M), aged 
between 7 and 17 years represented the studied group. All the children 
present diabetes mellitus type 1.  
 
Methods Of Investigation  
The methods of investigation were represented by clinical data - case 
history, current status, imagistic- thyroid ultrasound, biochemical - for 
European Scientific Journal   November 2013  edition vol.9, No.33  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
93 
 
glycemic balance: fasting blood glucose, glycosylated hemoglobin, 
investigation of the thyroid gland: TSH, FT4, FT3, thyroid antibodies. 
 
Investigation of glycemic balance  
Determination of plasma glucose was performed by enzyme 
technique with glucosooxidasis. Normal values were taken between 70 - 110 
mg%; diabetes mellitus - values equal or over 126 mg%, impaired glucose 
tolerance - values between 110 - 125 mg% and the OGTT at 2 h between 140 
- 200 mg% and impaired fasting glucose - values between 110 - 125 mg% 
and OGTT at 2 h under 140 mg%.  
Determination of HbA1c was achieved through the DiaStat for 
measuring HbA1c reported to the total HbA.  
 
Investigation of the thyroid gland 
To determine the TSH level in plasma, the free fraction of 
triiodotironin (FT3), and the plasma free fraction of thyroxin (FT4) were 
performed a quantitative method ARCHITECT; witch is an immunological 
method, Chemilumnescent Microparticle Immunoassay (CMIA). Normal 
values were following: TSH = 0.465-4.68 Miu/ml, FT3 = 3.69 -10.4 pmol/l, 
FT4 = 10-28.2 pmol/l.  
The immunological parameters were represented by autoimmune 
thyroid markers - antibodies (antiTPO and antiTg antibodies).  
To determine serum levels of antiTPO antibodies it was used the kit 
AxSYM antiTPO, an immunological method (Microparticle Enzyme 
Immunoassay) (MEIA). Normal values:  antiTPO antibodies <35 IU/ml.  
To determine serum levels of antiTg antibodies it was used the kit 
AxSYM antiTg, a MEIA method as well (Microparticle Enzyme 
Immunoassay). Normal values: antiTg antibodies <55 IU/ml.  
Thyroid ultrasound was performed in all cases and allowed us to 
measure thyroid volume, thyroid study and the changes in parenchyma’s 
density.  
An increased density, uniform, characterizes normal thyroid parenchyma 
easily distinguished from the neck muscles that are hypo dens.  
Inflammatory processes and autoimmune pathology appears hypo 
dens.  The scale was assessed as being discreet +, moderate ++ and marked 
+++.  
In the autoimmune thyroid disease the parenchyma of the gland 
appears hypo dens.  
In Grave’s disease is seen an increased volume of the thyroid, 
hypoecogenity of different intensities with variable homogeneity in the 
thyroid parenchyma.  
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Chronic autoimmune thyroid disorder appears with a hypoecogenity 
of the parenchyma and normal or increased thyroid volume.  
 
Statistical Analysis 
For statistical analysis we used Microsoft Excel and POP Tools from 
Microsoft Office 2003 and EPI 2000 program. To measure the quantitative 
variables were determined media (M) and standard deviation (SD), and to 
assess the gender differences we used the unpaired t test and ANOVA test, 
considering statistically significant a p < 0.05. 
 
Results And Discussion 
The group of children was represented by 83 subjects aged between 
7-17 years (Table I). All the subjects from the study had diabetes mellitus 
type 1.  
Table I. Distribution by age and gender of children and adolescents group 
Age Cases number Female Male 
 n % n % n % 
0 -  4 years - - - - - - 
5 - 9  years 2 2.4 2 100 - - 
10 – 14 years 32 38.56 22 68.75 10 31.25 
15 – 17 years 49 59.04 47 95.92 2 4.08 
 
Type 1 diabetes is the most common type of diabetes found in 
children and adolescents, represented the main cause of disease in 
Caucasians of northern Europe, especially in Scandinavian [Karvonen et al, 
2000]. 
In the studied group, the gender distribution of the children was 5.9 / 
1, represented by 71 girls (85.54%) and 12 boys (14.45%) (Fig.1). Compared 
to the literature, we found a net predominance of females, probably due to 
the DM type 1 association with thyroid disorders, frequent especially in 
women. The differences between male and female, on the prevalence of type 
1 diabetes cases were highly significant (X2 = 83.33, p <0.001) in the group 
of children and adolescents. 
Fig 1. The gender distribution of the children 
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In general, type 1 diabetes affects boys and girls equally [Gale et al, 
2001]. In populations with low risk of type 1 diabetes as Japanese and 
African-Americans, there is a preponderance of females, while in 
populations at high risk for type 1 diabetes there is a predominance of male 
patients [Steck et al, 2004]. 
In Europe, all the populations with an incidence of diabetes over 
20/100000 (Sardinia, Great Britain, Finland, Italy, Norway etc.) has a 
predominance of male patients, while in the countries with a proportion of 
DM under 4.5/100000 (Baltic countries, Macedonia, Yugoslavia, Romania, 
etc.) is a predominance of females [Şerban et al, 2001]. 
In Romania there was a slight female predominance, which, overall, 
is not statistically significant, but that was highlighted by all studies 
conducted so far [Guja et al, 2004]. 
Regarding the type of thyroid disease, prevailed ACT, followed by 
euthyroid diffuse goiter and Graves-Basedow disease (Table 2). We note 
significance differences between ACT and euthyroid diffuse goiter (p<0.001, 
X2= 20.31), between ACT and Graves-Basedow disease (p<0.001, X2= 
66.25) and euthyroid diffuse goiter and Graves-Basedow disease (p<0.001, 
X2= 18.43).  
Table 2. Distribution of children and adolescents group by the type of thyroid disease 
Thyroid disorder 
type 
Cases number Group mean 
age (years) 
Female Male 
n % medie ± DS n % n % 
ACT 54 65.06 14 ± 2.4 47 87.03 7 12.97 
Euthyroid difusse 
goiter 
25 30.12 14 ± 1.93 20 80 5 20 
Graves-Basedow 
disease 
4 4.82 16 ± 0.5 4 100 - - 
Legend: ACT = autoimmune chronic thyroiditis 
 
A number of studies have found that autoimmune chronic thyroiditis 
with or without goiter is the most common thyroid disorder occurring in 
patients with type 1 diabetes. It is approximate that 1 from 5 children with 
diabetes have antithyroid antibodies. The prevalence is 2-20 times higher in 
patients with type 1 diabetes than in the general population [Micle, 2000]. 
Other authors estimated the incidence of Hashimoto thyroiditis in 
patients with type 1 diabetes at 20% [Mărginean et al, 2000]. The results are 
contradictory, because other studies suggest that the prevalence of 21.6% in 
autoimmune thyroid disease may be overestimated [Kalicka – Kasperczyk et 
al, 2002]. 
In the U.S., at the Caucasian population with type 1 diabetes has been 
reported a prevalence of 50% of the disease [Kordonouri et al, 2002]. 
Hashimoto's thyroiditis is the most common cause of hypothyroidism in the 
European Scientific Journal   November 2013  edition vol.9, No.33  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
96 
 
U.S. after the age of 6 years, with an estimated incidence of 1 3% in a 
sample of 5000 children aged between 11-18 years [Odeke et al, 2006]. 
A study from Australia shows that the incidence rate for thyroid 
disease in patients with type 1 diabetes is 0.9 / 100 patients / year [Glastras et 
al, 2005]. 
In the case of hyperthyroidism, the main cause in children is 
represented by Graves-Basedow disease. A U.S. study showed a prevalence 
of 30 cases per 100.000/year. Worldwide, it is estimated that Graves-
Basedow disease represents between 60-90% of thyrotoxicosis cases in 
different regions of the world [Yeung et al, 2005]. 
A study from Israel shows that the main cause of thyrotoxicosis in 
children is the Graves-Basedow disease; this represents 10-15% of thyroid 
disorders in this age [Kraiem et al, 2001]. Thyroid hyperfunction of other 
etiology is much less common in patients with DM type 1, the proportion 
being 1%. 
Regarding the gender distribution, we found a predominance of 
females in the study group, concordant aspect with the literature data, 
because thyroid disorders are more common in women. 
Thus, in the case of ACT, a percentage of 87.03% cases were female 
and 12.97% male, with an F / M ratio of 6.7 / 1, the differences being highly 
significant (X2 = 59.26, p < 0.001). In the literature, in the case of 
Hashimoto's thyroiditis it is shown that this is 10-15 times more common in 
women [Odeke et al, 2006]. 
In the case of euthyroid diffuse goiter, 80% of cases were female and 
20% male, F / M ratio was 4/1, also highly significant differences (X2 = 18, p 
<0.001). In the world, the euthyroid diffuse goiter frequency is about 5%, 
usually occurs around puberty and it is more common in females (F / M ratio 
= 1.2 - 4.3 / 1) [Lee et al, 2006]. 
In the case of Graves-Basedow disease all 4 patients were female. In 
the literature it is also show in this case a female predominance, the ratio F / 
M being 7-8/1 [Yeung et al, 2005]. 
A study in Greek on children with Graves-Basedow disease shows 
that female predominance is similar between children and adults (87% and 
83% respectively) [Krassas et al, 2006]. 
Another study in the Czech Republic show a predominance of female 
subjects with autoimmune thyroid disease (68% vs. 32%) [Vondra et al, 
2006]. 
In the study group, the onset mean age for Graves-Basedow disease 
was 15.75 ± 0.5 years, in the case of ACT 13.98 ± 2.46 years, and for 
euthyroid diffuses goiter 14.48 ± 1.93 years. 
A study in Taiwan on 106 children shows that in the case of Graves-
Basedow disease the onset minimum age was 3.36 years. The incidence of 
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disease increased progressively with age, with a peak at age 15 [Hung et al, 
2006]. 
Another study in Thailand on 154 children with euthyroid diffuse 
goiter showed that the onset mean age was 12.8 ± 1.8 years [Jaruratanasirikul 
et al, 2000]. 
In Germany the study conducted in patients with autoimmune 
thyroiditis showed that the onset age for this was between 5.4 and 16.3 years, 
with a median of 11.3 years [Doeker et al, 2000]. 
Depending on the duration of thyroid disease, all 83 children from the 
study had an apparent duration of thyroid disease less than 5 years. A U.S. 
study on 1254 patients under 21 years has shown that autoimmune thyroid 
disorders are present in 4.2% of patients with type 1 diabetes of the study 
group. 39% from thyroid disease were diagnosed at 1 year after diabetes 
type1 and antiTPO antibodies were present in 90% of cases [Bilimoria et al, 
2003]. 
Depending on the type of thyroid disease in the group of children, we 
made three groups:  
- the group with Graves-Basedow disease 
- the group with ACT 
- the group with euthyroid diffuse goiter 
At every group we determined the actual mean age, the onset mean 
age of thyroid disease and diabetes, mean duration of diabetes and thyroid 
disease, mean BMI, glucose and HbA1c (Table 3). 
Significant differences between the 3 groups we obtain in the case of 
actual age, onset age of diabetes, thyroid disease and diabetes duration 
(Table 4). 
Thus, in the case of onset age of diabetes the lower age was in the 
case of ACT group (5.42 ± 3.87 years) and the higher in the case of Graves-
Basedow disease (16.75 ± 0.5 years). 
The shortest duration of DM was found in patients with Graves-
Basedow disease (0.25 ± 0.5 years) and the longest for ACT (9.07 ± 3.76 
years). 
In the case of thyroid disease duration the shortest was in the case of 
euthyroid diffuse goiter group, followed by the ACT group (0.48 ± 0.94 
years) and Graves-Basedow disease group (1.25 ± 0.5 years). 
We not obtained significant differences regarding BMI, blood 
glucose and HbA1c. 
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Table 3. Comparative data in function of type thyroid disease type in the group of children 
(mean ± SD) 
     
Table 4. Statistical differences (p) regarding thyroid disease parameters, depending on its 
type, in the group of children and adolescents 
Parameters Graves Basedow 
disease  vs. ACT 
Graves-Basedow 
disease vs. euthyroid 
difusse goiter 
ACT vs. 
euthyroid difusse 
goiter 
Actual age (years) < 0.001 < 0.001 < 0.001 
Onset age of thyroid 
disease (years) 
0.0004 0.01 0.33 
Onset age of DM 
(years) 
< 0.001 < 0.001 0.0007 
DM duration (years) < 0.001 < 0.001 0.0003 
Thyroid disease 
duration (years) 
0.04 0.01 0.0004 
BMI (kg/m2) 0.0044 0.08 0.41 
Glycemia (mg%) 0.28 0.31 0.45 
HbA1c (%) 0.27 0.44 0.02 
 
Conclusion 
In children with type 1 diabetes we found a net predominance of 
female and were prevailed autoimmune diseases such as part of the 
polyglandular autoimmune syndrome. 
Because thyroid disorder occurring in a certain period of time after 
diabetes, it is necessary to determine the possibility of association of 
autoimmune diseases, especially for thyroid diseases (higher risk for those 
with autoimmune chronic thyroiditis for hypothyroidism) for all children 
with type 1 diabetes mellitus.  
The methods  recommended are the dosage of antithyroid antibodies 
at children and adolescents with type 1 diabetes at the onset of diabetes, or at 
the latest before puberty, and if they are positive, should be tested the thyroid 
Parameters Graves–Basedow 
disease 
Autoimmune chronic 
thyroiditis 
Euthyroid difusse 
goiter 
Actual age (years) 16.75 ± 0.5 14.46 ± 2.4 14.48 ± 1.93 
Onset age of thyroid 
disease (years) 
15.75 ± 0.5 13.98 ± 2.46 14.48 ± 1.93 
Onset age of DM (years) 16.75 ± 0.5 5.42 ± 3.87 9.24 ± 4.52 
DM duration (years) 0.25 ± 0.5 9.07 ± 3.76 5.16 ± 4.37 
Thyroid disease duration 
(years) 
1.25 ± 0.5 0.48 ± 0.94 0 ± 0 
BMI (kg/m2) 23.12 ± 0.97 20.63 ± 2.69 21.39 ± 4.19 
Glycemia (mg%) 355  ± 309.5 154.72 ± 64.78 166.92 ± 67.68 
HbA1c (%) 13.72 ± 7.51 8.7 ± 2.06 10.37 ± 3.34 
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function and due the thyroid ultrasound to minimize the risk of undiagnosed 
hypothyroidism in young patients with type 1 diabetes. 
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